Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvement (Q42276279)
Jump to navigation
Jump to search
scientific article published on June 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvement |
scientific article published on June 1995 |
Statements
1 reference
Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvement (English)
1 reference
H Tohgi
1 reference
T Abe
1 reference
K Yamazaki
1 reference
M Saheki
1 reference
S Takahashi
1 reference
Y Tsukamoto
1 reference
1 reference
Identifiers
1 reference